HOME
ABOUT
About Adial
Management
Board of Directors
ADDICTION
Alcohol Addiction
Limitations of Current AUD Therapies
Our Proposed Solution
TECHNOLOGY
Overview
Phase 2b Clinical Trial Results
History of Ondansetron Use for AUD
Strengths and Competitive Advantages
Newsroom
Press Releases
Media
INVESTORS
Overview
Analyst Coverage
News / Events
Company Information
Financial Information
Stock Data
SEC Filings
Corporate Governance
CONTACT
Contact Us
Sign Up For Email Alerts
HOME
ABOUT
About Adial
Management
Board of Directors
ADDICTION
Alcohol Addiction
Limitations of Current AUD Therapies
Our Proposed Solution
TECHNOLOGY
Overview
Phase 2b Clinical Trial Results
History of Ondansetron Use for AUD
Strengths and Competitive Advantages
INVESTORS
Overview
Analyst Coverage
News / Events
Company Information
Financial Information
Stock Data
SEC Filings
Corporate Governance
CONTACT
All SEC Filings
Investor Relations
Investor Relations
Overview
Analyst Coverage
News / Events
Company Information
Financial Information
Stock Data
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Corporate Governance
Filing Type:
View All
10-K
10-Q
3
4
4/A
424B3
424B4
424B5
8-A12B
8-A12B/A
8-K
8-K/A
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFR14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
POS AM
RW
S-1
S-1/A
S-3
S-3/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
UPLOAD
Year:
View All
2022
2021
2020
2019
2018
2017
2013
2011
Date
Form
Description
PDF
XBRL
Pages
06/24/22
POS AM
Post-effective amendment to a registration statement that is not immediately effective upon filing
Documents
EX-5.1
EX-23.1
EX-FILING FEES
116
06/24/22
POS AM
Post-effective amendment to a registration statement that is not immediately effective upon filing
Documents
EX-5.1
EX-23.1
EX-FILING FEES
117
05/16/22
8-K
Current report filing
Documents
EX-99.1
4
05/16/22
10-Q
Quarterly report pursuant to Section 13 or 15(d)
Documents
EX-31.1
EX-31.2
EX-32.1
EX-32.2
25
04/12/22
424B3
Prospectus filed pursuant to Rule 424(b)(3)
14
04/08/22
EFFECT
Notice of Effectiveness
1
04/06/22
CORRESP
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
1
04/06/22
S-3/A
Registration statement for specified transactions by certain issuers
Documents
EX-23.1
6
03/31/22
CORRESP
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
2
03/28/22
10-K
Annual report pursuant to Section 13 and 15(d)
Documents
EX-3.3
EX-10.43
EX-21.1
EX-23.1
EX-31.1
EX-31.2
EX-32.1
EX-32.2
113
1
2
3
4
5
6
7
8
9
10